BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30726290)

  • 21. Compliance with prophylactic platelet transfusion trigger in haematological patients.
    Eikenboom JC; van Wordragen R; Brand A
    Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric Plasma and Platelet Transfusions on Extracorporeal Membrane Oxygenation: A Subgroup Analysis of Two Large International Point-Prevalence Studies and the Role of Local Guidelines.
    Nellis ME; Saini A; Spinella PC; Davis PJ; Steiner ME; Tucci M; Cushing M; Demaret P; Stanworth SJ; Leteurtre S; Karam O;
    Pediatr Crit Care Med; 2020 Mar; 21(3):267-275. PubMed ID: 31644453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
    Stanworth SJ; Dyer C; Choo L; Bakrania L; Copplestone A; Llewelyn C; Norfolk D; Powter G; Littlewood T; Wood EM; Murphy MF;
    Transfus Med Rev; 2010 Jul; 24(3):163-71. PubMed ID: 20656185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children With an Underlying Oncologic Diagnosis.
    Nellis ME; Goel R; Karam O; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC;
    Pediatr Crit Care Med; 2019 Jul; 20(7):e342-e351. PubMed ID: 31107379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia.
    Josephson CD; Granger S; Assmann SF; Castillejo MI; Strauss RG; Slichter SJ; Steiner ME; Journeycake JM; Thornburg CD; Bussel J; Grabowski EF; Neufeld EJ; Savage W; Sloan SR
    Blood; 2012 Jul; 120(4):748-60. PubMed ID: 22538854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
    Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
    Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
    Stanworth SJ; Hyde C; Brunskill S; Murphy MF
    Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expected individual benefit of prophylactic platelet transfusions in hemato-oncology patients based on bleeding risks.
    Cornelissen LL; Caram-Deelder C; Fustolo-Gunnink SF; Groenwold RHH; Stanworth SJ; Zwaginga JJ; van der Bom JG
    Transfusion; 2021 Sep; 61(9):2578-2587. PubMed ID: 34263930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective observational study of low thresholds for platelet transfusion in adult dengue patients.
    Thomas L; Kaidomar S; Kerob-Bauchet B; Moravie V; Brouste Y; King JP; Schmitt S; Besnier F; Abel S; Mehdaoui H; Plumelle Y; Najioullah F; Fonteau C; Richard P; Césaire R; Cabié A
    Transfusion; 2009 Jul; 49(7):1400-11. PubMed ID: 19320862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet Transfusions in Pediatric Intensive Care.
    Du Pont-Thibodeau G; Tucci M; Robitaille N; Ducruet T; Lacroix J
    Pediatr Crit Care Med; 2016 Sep; 17(9):e420-9. PubMed ID: 27472254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A no-prophylaxis platelet-transfusion strategy for hematologic cancers.
    Stanworth SJ; Estcourt LJ; Powter G; Kahan BC; Dyer C; Choo L; Bakrania L; Llewelyn C; Littlewood T; Soutar R; Norfolk D; Copplestone A; Smith N; Kerr P; Jones G; Raj K; Westerman DA; Szer J; Jackson N; Bardy PG; Plews D; Lyons S; Bielby L; Wood EM; Murphy MF;
    N Engl J Med; 2013 May; 368(19):1771-80. PubMed ID: 23656642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients.
    Diedrich B; Remberger M; Shanwell A; Svahn BM; Ringdén O
    Transfusion; 2005 Jul; 45(7):1064-72. PubMed ID: 15987349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different Platelet Count Thresholds to Guide Use of Prophylactic Platelet Transfusions for Patients With Hematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation.
    Estcourt LJ; Stanworth SJ; Murphy MF
    JAMA Oncol; 2016 Aug; 2(8):1091-2. PubMed ID: 27415031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits of lower neonatal platelet transfusion thresholds.
    Hasan R; Saifee NH
    Transfusion; 2021 Jun; 61(6):1672-1675. PubMed ID: 33786866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect and duration of prophylactic platelet transfusions before insertion of a central venous catheter in patients with bone marrow failure evaluated with point-of-care methods and flow cytometry.
    Kander T; Tanaka KA; Norström E; Persson J; Schött U
    Anesth Analg; 2014 Oct; 119(4):882-890. PubMed ID: 24854870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry.
    Ning S; Barty R; Liu Y; Heddle NM; Rochwerg B; Arnold DM
    Chest; 2016 Sep; 150(3):516-23. PubMed ID: 27102183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoplatelet counting: potential for reducing the use of platelet transfusions through more accurate platelet counting.
    Norris S; Pantelidou D; Smith D; Murphy MF
    Br J Haematol; 2003 May; 121(4):605-13. PubMed ID: 12752102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
    Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
    Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit.
    Gerday E; Baer VL; Lambert DK; Paul DA; Sola-Visner MC; Pysher TJ; Christensen RD
    Transfusion; 2009 Oct; 49(10):2034-9. PubMed ID: 19555422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.